InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,848.80
(
0.01%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
85.43
(
-1.25%
)
Bitcoin
57,640.79
(
3.21%
)
Post# of 21373
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DayDreeming

Send PM Follow Ignore
Followers 4
Posts 687
Boards Moderated 0
Alias Born 09/27/2016

DayDreeming

Re: None

Wednesday, 09/13/2017 4:23:39 PM

Wednesday, September 13, 2017 4:23:39 PM

Post# of 21373
More dilution......

Note 7 - Related-Party Transactions

As of December 31, 2016, GHC was the majority stockholder of Oncolix, and GHC is an affiliate of GHS. An affiliate of GHS is the site for clinical trial activities. Accounts payable to GHC and GHS for services approximated $61,935 and $22,911 at December 31, 2016 and 2015, respectively.

We have engaged a contract manufacturer and clinical research firms and certain of the costs incurred have been paid or will be paid through the issuance of capital stock.

Source: S-1 from 8/29/17
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up